Найкращі дитячі онкологи – ТОП-388 лікарів

Education

• Ege Faculty of Medicine 1978
• Specialization in Pediatrics 1982
• Subspecialty Pediatric Oncology 2002 (EU Faculty of Medicine)
• Pediatric Hematology and Oncology 2012 (EU Faculty of Medicine)
• Deputy Chief of Clinic 1988 Tepecik EAH
• Clinical Chief 1993 Tepecik EAH
• Associate Professorship 1995
• Professorship  2002
• Ege U. Faculty of Medicine, faculty member 1998 – 2022
• EU Faculty of Medicine Department of Pediatrics 2009-2018
• Member of Tepecik Education Planning and Coordination Board (1993-1998)
• SSI Tepecik Hospital Ethics Committee Chairman (1996-1998)
• Turkish Society of Pediatric Hematology "Bone Marrow Transplantation Working Group Co-Chair" (2002-2006)
• Turkish Society of Pediatric Hematology "Bone Marrow Transplantation Working Group" (2006-2008)
• Turkish Society of Pediatric Hematology - Responsible for Bone Marrow Transplantation "Online" Data Registry System 2007-ongoing.
• Ege University Regenerative Medicine and Stem Cell Commission Chairman, 2011-2021

Institutional Memberships

• Turkish Medical Association İzmir and Kocaeli Branch
• Turkish National Pediatric Association - İzmir
• European Group for Bone Marrow Transplantation (EBMT); Ege University Pediatric Bone Marrow Transplantation Unit was accredited by the European Group for Bone Marrow Transplantation (EBMT) in June 2007.
• Turkish Society of Pediatric Hematology - Board Member for two terms (2005-2009)
• Turkish Society of Hematology - Board Member for two terms (2001/2005)
• Turkish Pediatric Oncology Association
• Bone Marrow Transplantation Foundation (KITVAK) Member of the Board of Trustees

Units he is the founder of                        

1- SSI Tepecik Hospital Pediatric Oncology Clinic (1990) 
2- SSI Tepecik Hospital Pediatric Bone Marrow Transplantation Unit (1992) 
3- EU Faculty of Medicine Pediatric Bone Marrow Transplantation Unit (1998) 
4- FOUNDER of JOURNAL OF PEDIATRIC RESEARCH, 2014; SCI application was made in 2022.  

Transplantation units that he contributed to the establishment of                        

1. İzmir BUÇH EAH Pediatric Bone Marrow Transplantation Unit (2019) 
2. Ümraniye EAH Pediatric Bone Marrow Transplantation Unit (2020) 
3. Kanuni Sultan Süleyman EAH Pediatric Bone Marrow Transplantation Unit (2020) (Transferred to Çam Sakura EAH)

Awards

• Thrombotic parameters in bone marrow stem cell transplant patients, Pediatric Hematology Congress, Trabzon 2003
• CD133 Antigen in Stem Cell: Pediatric Hematology Congress 2005. Research award
• The role of Toll like receptors in febrile neutropenic patients, Best poster award. Turkish Hematology Congress 2008, Çeşme-İzmir
• National pediatric stem cell transplantation activity- Oral presentation second prize, Turkish Hematology Society Stem Cell Transplantation Congress, 2022, Antalya

Publications

Kansoy S. "Bone Marrow and Stem Cell Transplantation Child Health and Diseases, 1st edition, EU Faculty of Medicine Printing House, 1999, İzmir

Kansoy S. Bone marrow transplantation in Thalassemia Major III. Aegean Thalassemia Days Book, 2000, Izmir

Kansoy S. Pediatric KIT Center Standards in Turkey. Childhood Acute Leukemias, Antalya 2000: 73-5

Kansoy S. Late Side Effects in Children. Special issue of Bone Marrow Transplantation Journal of Turkish Clinics. 2003

Kansoy S. Stem Cell Applications in Bone Marrow and Stem Cell Transplantation. Pediatric Oncology Nursing Course Book, İzmir, 2005

Kansoy S. Cord Blood as a Stem Cell Source. Stem Cell Special Issue. Turkey Clinics, 2008

Kansoy S. Stem Cell Transplantation in Lymphomas. General Pediatrics Book, Ed. Prof.Dr.Enver Hasanoglu, 2009

Kansoy S, Aksoylar S. Bone Marrow Transplantation in Children. Pediatrics, 2014 and 2017

Kansoy S. Rhabdomyosarcoma. Pediatrics, 2014 and 2017

Kansoy S. Approach to the child with cancer according to clinical findings. Pediatrics, 2014 and 2017 

11. Çetingül N, S.Kansoy, M.Kantar. Oncological Diseases. Pediatrics (Ed. A. Cura), 641-672, Ege University Print house, İzmir, 1999.  (1.05 points)

Kansoy S, M.Kantar. Head, Face and Eye Examination. Pediatric Prosthetic Physical Examination and Symptom Information (Ed. A.Cura)

Kantar M. Metabolic Emergency Problems in Oncology. Oncologic Emergencies and Supportive Care in Childhood (Ed. N. Çetingül, S. Kansoy), 15-24, Meta Basım, İzmir, 2003. 

Cord Blood Transplants in Turkey. HEMATOLOGIST, 2016

Kansoy S. Central Nervous System Tumors in Children Pediatrics, 2014 and 2017

Acute myeloblastic leukemia in children and its treatment. Pediatric Oncology Textbook, Poplack's Turkish, 2020

National pediatric stem cell transplant activity, 2020

Childhood stem cell transplantation indications, Turkey Clinics - International book 2020

In addition to the studies and papers in international journals published in large numbers, he is involved in international multicenter studies in some journals with high impact value.

Дитячий онкогематолог, фахівець із пересадки кісткового мозку

Дитячий онколог, хірург

Професор д-р Райнер Котц є висококваліфікованим хірургом-ортопедом-онкологом із понад 50-річним стажем роботи, який закінчив Віденський університет і отримав диплом з педіатричної ортопедії пухлин у США. Він був нагороджений численними відзнаками, такими як золота медаль Віденського університету, медаль Генрі Дюнана від Червоного Хреста, почесна медаль Міністерства охорони здоров’я Австрії, нагорода Ервіна-Шредінгера в 2005 році та MUVI Покровитель 2007 рік.

Професор Шломі Константіні є висококваліфікованим нейрохірургом в Ізраїлі, який має досвід у загальній та дитячій нейрохірургії, мікрохірургічних операціях, реконструктивних втручаннях і лікуванні пухлин головного мозку та хребта. Він отримав кілька нагород і є членом багатьох професійних організацій.

Доктор Дрор Левін є старшим педіатром і директором відділень захворювань крові та лікування раку кісток (саркоми) у дитячій лікарні «Дана» та медичному центрі «Сураскі» відповідно. Він спеціаліст з педіатрії, гематології та онкології, має додатковий досвід навчання за кордоном в Ортопедичному інституті Ріццолі в Італії.

Undergraduate and Doctoral Education:

* 1992-1999 Ondokuz Mayıs University Faculty of Medicine

* 2002-2007 Inonu University, Faculty of Medicine, Child Health and Diseases,

Pediatrics Residency

* 2015-2018 Inonu University, Faculty of Medicine, Pediatrics, Pediatric

Hematology and Oncology Subspecialization

*2017-Ankara University, Pediatrics, Oncology minor residency (8 months)

EXPERIENCE*

2019 - Present, Istanbul/Istanbul/Turkey

MEMORIAL ATAŞEHİR HOSPITAL

General Surgeon

2012 - 2019, Diyarbakır/Diyarbakır/Turkey

DİCLE UNIVERSITY FACULTY OF MEDICINE

General Surgeon

2011 - 2012, Van/Van/Turkey

VAN REGIONAL TRAINING AND RESEARCH HOSPITAL

General Surgeon

2009 - 2011, Van/Van/Turkey

HAKKARİ STATE HOSPITAL

General Surgeon

2004 - 2009, Van/Van/Turkey

YÜZÜNCÜYIL UNIVERSITY FACULTY OF MEDICINE

General Surgeon

2002 - 2004, Van/Van/Turkey

HACIBEKİR HEALTH CENTER

General Practitioner

*EDUCATION*

2018 - 2019, Diyarbakır/Turkey

Associate Professor

2015, Ohio/USA

OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER

Neck Dissection Training

2012 - 2018, Diyarbakır/Turkey

Assistant Professor

1996 - 2002, Adana/Turkey

ÇUKUROVA UNIVERSITY

FACULTY OF MEDICINE - Medical Doctor Education

Biography

Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:

• Oncology care and treatment for chemotherapy, hormonal therapy, immune therapy, and target therapy
• Breast cancer
• Solid tumor diagnosis
• Digestive cancer
• Gynecological cancer
• Lung cancer
• Genitourinary cancer
• Sarcoma

Awards & Achievements

• Award from Himaya Foundations and University of Sharjah

Research & Publications

• Clinicopathological Features of Gastric Cancer in a Cohort of Gulf Council Countries' Patients: A Cross-Sectional Study of 96 Cases. Journal of Oncology Research Reviews & Reports Volume 2(2): 1-3.
• The Burden of Gynecologic Cancers in the UAE. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
• The Emirates Oncology Task Force Clinical Practice Guideline on Screening for SARS-CoV-2 in Asymptomatic Adult Cancer Patients Before Anti-Cancer Therapy. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
• The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. Humaid Al-Shamsi, Humaa Darr, Ibrahim Abu-Gheida , Jawaher Ansari, Martine, Mehdi Afrit, Mohamad H Masri, Mohamed Abuhaleeqa. Gulf J Oncology 2020 Jan;1(32):71-87.
• Primary Bone Lymphoma: Tunisian Multicentric Retrospective Study About 32 Cases. Ben Ayed C, Laabidi S, Said N, Afrit M, Ben Ahmed S, Boussen H. Tunis Med. 2018 May;96(5):269-272.
• First Site of Recurrence After Breast Cancer Adjuvant Treatment in the Era of Multimodality Therapy: Which Imaging for Which Patient During Follow-up? Nesrine M, Mehdi B, Houda EB, Soumaya L, Mehdi A, Bechir Z, Hamouda B. Breast Dis. 2017 Nov 21